Highly doubtful. If they didn't have enough to serve a measly 300 people , how could they claim to the FDA to have any stockpile of Ryoncil on Sep 30 approval to allow immediate treatment, I think that is a pre-requisite of approval.
Now that they are moving the manufacturing into one of the US labs, that also has a couple of massive - 2000 and 1000 liter bioreactors.... getting enough treatment is not going to be an issue - it has never been identified by the company as being an issue. They pay lonza, and lonza produce. ?
Ann: COVID-19/GVHD Update, Quarterly Report and Appendix 4C, page-225
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.020(1.78%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.13 | $1.09 | $4.556M | 4.141M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9590 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 3132 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |